--- title: "Abbvie | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 16.99 B" type: "News" locale: "en" url: "https://longbridge.com/en/news/294508723.md" datetime: "2026-07-31T11:53:42.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294508723.md) - [en](https://longbridge.com/en/news/294508723.md) - [zh-HK](https://longbridge.com/zh-HK/news/294508723.md) generator: "portal-rs" --- # Abbvie | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 16.99 B Revenue: As of FY2026 Q2, the actual value is USD 16.99 B, beating the estimate of USD 16.76 B. EPS: As of FY2026 Q2, the actual value is USD 2.03, beating the estimate of USD 1.9107. EBIT: As of FY2026 Q2, the actual value is USD 6.432 B. The provided reference, a Form 8-K filing by AbbVie Inc. dated July 31, 2026, announces the issuance of a press release detailing the company’s financial results for the second quarter ended June 30, 2026. However, the actual financial metrics, operational data, cash flow information, or outlook/guidance are not included within this Form 8-K document itself. These details are furnished as Exhibit 99.1 to the report and incorporated by reference, which is not provided in the current text for analysis. ### Related Stocks - [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md) ## Related News & Research - [Trivium Point Advisory LLC Increases Stock Holdings in AbbVie Inc. $ABBV](https://longbridge.com/en/news/297292955.md) - [China approves J&J's oral psoriasis pill, says drugmaker](https://longbridge.com/en/news/297158718.md) - [WhiteFiber amends 8-K to file real estate purchase and sale agreement as exhibit](https://longbridge.com/en/news/297088090.md) - [Northann amends 8-K to file former auditor LAO Professionals’ letter on resignation](https://longbridge.com/en/news/296825824.md) - [HRL: Raised fiscal 2026 adjusted EPS guidance after strong adjusted earnings and cash flow](https://longbridge.com/en/news/297163071.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**